Ferrari NV vs 10X Genomics Inc — how do they compare? Ferrari NV trades at $371.61 (market cap $65.25B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Ferrari NV is far larger — about 11.9× 10X Genomics Inc's market cap, and Ferrari NV pays a 1.14% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| RACE | TXG | |
|---|---|---|
Market Cap | $65.25B | $5.48B |
Sector | Consumer Cyclical | Health |
52-Week High | $517.65 | $47.20 |
52-Week Low | $314.63 | $11.34 |
Enterprise Value | $66.46B | $5.02B |
Dividend Yield | 1.14% | — |
Trailing returns across standard periods
Latest headlines on both assets
Ferrari engineers and manufactures some of the world's most expensive exotic sports cars. The Ferrari brand is synonymous with Formula One racing, exclusivity, Italian design, and state-of-the-art technology. Ferrari also has a captive finance company that provides funding for dealers and clients.
Read more on RACE →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →